Clinical Trials on Metastatic Well Differentiated Neuroendocrine Neoplasm in Germany
Total 2612 results
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbHCompletedNeuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditionsGermany
-
Ludwig-Maximilians - University of MunichUnknownMelanoma | Radiotherapy | Metastatic DiseaseGermany
-
Dermatologic Cooperative Oncology GroupUnknown
-
University of JenaUnknownNeuroendocrine Tumors | Metastasis | LiverGermany
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
Charite University, Berlin, GermanyUnknown
-
University of RegensburgUnknown
-
Fachklinik Hornheide an der Universität MünsterUnknownAdvanced Metastastic Malignant Melanoma | Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue MetastasesGermany
-
Hasumi International Research FoundationActive, not recruitingMelanoma, Uveal MetastaticGermany
-
Philogen S.p.A.Active, not recruiting
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
University Hospital AugsburgRecruitingNeoplasms | Neoplasm Metastasis | Metastatic CancerGermany
-
University Hospital TuebingenCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
University Hospital, BonnMundipharma Research GmbH & Co KGTerminatedLeptomeningeal Metastasis From Malignant MelanomaGermany
-
Johannes Gutenberg University MainzIpsen; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA...Active, not recruiting
-
Carmen Schade-BrittingerCompletedNeuroendocrine TumorsGermany
-
Eli Lilly and CompanyCompletedSolid Tumor | Malignant Solid Tumor | Metastatic TumorGermany, United States, France
-
University Hospital AugsburgRecruitingSolid Tumor | Metastatic Cancer | Characteristics DiseaseGermany
-
Novartis PharmaceuticalsCompletedMetastatic Melanoma and Merkel Cell CarcinomaGermany, Switzerland
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
University Hospital TuebingenTerminatedMetastatic Melanoma | Brain MetastasesGermany
-
Boehringer IngelheimRecruitingNeuroendocrine NeoplasmsUnited States, Spain, Germany, Japan, France
-
Johannes Gutenberg University MainzTerminated
-
Hoffmann-La RocheCompletedMetastatic MelanomaFrance, Italy, Spain, Brazil, Latvia, Germany, Hungary, Switzerland
-
Charite University, Berlin, GermanyRecruiting
-
Dermatologic Cooperative Oncology GroupRecruiting
-
AB ScienceTerminatedMetastatic MelanomaFrance, Spain, Italy, United States, Czechia, Germany, Russian Federation
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
Eli Lilly and CompanyCompletedColorectal Cancer | Metastatic Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Germany
-
Wuerzburg University HospitalRecruitingGastrointestinal CancerGermany
-
SanofiBioNTech RNA Pharmaceuticals GmbHTerminatedMetastatic NeoplasmFrance, Spain, United States, Belgium, Germany, Netherlands
-
European Organisation for Research and Treatment...CompletedDifferentiated Thyroid Cancer (DTC) | Medullary Thyroid Cancer (MTC)France, Belgium, Denmark, Italy, Netherlands, Germany, Poland, Spain, United Kingdom
-
Ludwig-Maximilians - University of MunichCompletedMetastatic Renal CancerGermany
-
Johannes Gutenberg University MainzMerck KGaA, Darmstadt, GermanyCompleted
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
Jena University HospitalUniversity Hospital TuebingenRecruitingColorectal Cancer Metastatic | Liver MetastasesGermany
-
Heidelberg UniversityUniversity Hospital Tuebingen; SLK Kliniken Heilbronn GmbHUnknownStage IV Melanoma Patients With Unresectable Liver MetastasesGermany
-
University of RegensburgCompletedLiver Neoplasms | Surgery | Colorectal Cancer Metastatic | Ultrasound | Metastases | Liver/Hepatobiliary CancerGermany
-
Federation Francophone de Cancerologie DigestiveTerminatedMetastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine TumoursFrance, Belgium, Germany, United Kingdom
-
Eisai Inc.CompletedMetastatic MelanomaUnited States, Australia, United Kingdom, Germany
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Germany, Belgium, Japan, France
-
Johann Wolfgang Goethe University HospitalUnknownColorectal Cancer | Metastatic CancerGermany
-
Maastricht University Medical CenterKU Leuven; University College, London; Erasmus Medical Center; Catholic University... and other collaboratorsActive, not recruitingNSCLC Stage IV | Metastatic DiseaseNetherlands, Belgium, United Kingdom, Germany, France, Italy
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Novartis PharmaceuticalsCompletedCarcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non FunctioningSweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
-
PfizerCompletedBRAF or NRAS Mutant Metastatic MelanomaUnited States, Netherlands, Italy, Germany, Switzerland
-
University Hospital TuebingenUniversity Hospital DresdenUnknownMalignant Melanoma | MetastasesGermany
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands